Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Equinox Gold Announces Sale of Shares of Versamet Royalties
-
United States Mint Strikes Limited-Edition 2.5-Ounce Silver Fourth of July Declaration of Independence Quarters
-
Viking Acquisition Corp. II Announces Closing of $230 Million Initial Public Offering
-
The World's Largest Flying Canvas Takes Flight: STARLUX AIRSORAYAMA Silver Redefines Art in the Sky
-
Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Decrease in June 2026 of 5.1% Compared to 2025
-
Syntiant Publicly Files Registration Statement for Proposed Initial Public Offering
-
AGF Reports June 2026 Assets Under Management and Fee-Earning Assets
-
Exyn Technologies Reports First Quarter 2026 Financial Results Successfully Completed Initial Public Offering, and Continued Expansion of ExynAI Across Commercial and Government Markets
-
MemeToro Releases Tokenomics Presale Audit to Increase Presale Transparency
-
Cloudastructure Strengthens Balance Sheet with Elimination of Variable Conversion Debt Feature and Provides Update on First Quarter 2026 Filing
-
Postal Realty Enhances Capital Structure with Credit Facility Recast
-
Dorchester Minerals, L.P. Announces Agreement to Acquire Mineral and Royalty Interests
-
SalesCloser Technologies to Commence Trading on the OTCQB Venture Market
-
Plumbing Detectives LLC Expands Polybutylene Pipe Inspection Services as Sarasota County Homeowners Face Insurance Coverage Challenges
-
Electra Provides Quarterly Update on Capital Markets Activity and Equity Participation Programs
-
Innospec Schedules Second Quarter 2026 Earnings Release and Conference Call
-
IPG Launches High-Performance Sustainable Air Pillow Film With 50% Recycled Content
-
Plains All American Pipeline and Plains GP Holdings Announce Quarterly Distributions and Timing of Second Quarter 2026 Earnings
-
USCB Financial Holdings, Inc. to Announce Second Quarter 2026 Results
-
Cal-Maine Foods Schedules Fourth Quarter and Fiscal Year 2026 Earnings Release, Conference Call and Webcast
-
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
-
Mercer International Inc. Announces Conference Call for Second Quarter 2026 Results
-
Wintrust to purchase Northern Trust guardianship services business
-
CubeSmart Announces the Date of Its Second Quarter 2026 Earnings Release and Conference Call
-
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
-
Lamar Advertising Company to Release Second Quarter Ended June 30, 2026 Operating Results
-
Celestica Q2 2026 Financial Results and Conference Call Tuesday, July 28, 2026
-
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
-
American Assets Trust, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call Information
-
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
-
Vireo Growth Inc. Engages Independent Trading Group (ITG), Inc. as Market Maker
-
SEALSQ Corp Reports Preliminary H1 2026 Results; Revenue up 120%, FY 2026 Guidance Reaffirmed
-
Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes
-
Kalaris Appoints Laurie Keating to Board of Directors
-
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
-
PennantPark Floating Rate Capital Ltd. Schedules Earnings Release of Third Fiscal Quarter 2026 Results
-
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
PennantPark Investment Corporation Schedules Earnings Release of Third Fiscal Quarter 2026 Results
-
McFarlane Lake Announces C$6.2 Million in Warrant Exercises
-
Longeveron® Appoints Marie Washburn as Chief Financial Officer
-
Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering
-
Encore Capital Group to Announce Second Quarter 2026 Financial Results on August 5
-
Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
-
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
-
Navitas Semiconductor to Report Q2 2026 Financial Results on Monday, July 27, 2026
-
Valley National Bancorp to Announce Second Quarter 2026 Earnings
-
Abivax Announces Closing of $920 Million Public Offering
-
MemeToro Launches BNB AI Agent for Fair-Launch Memecoin Creation and On-Chain Prediction Markets
-
Mulvihill Split Capital Share ETF Declares Monthly Distribution
